Alpha 2.0
Login Register
» Authors » S Korsatko

S Korsatko

Explore the profile of S Korsatko including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 53
Followers 0
Related Specialties
Biomedical Engineering
Endocrinology
Pharmacology
Top 10 Co-Authors
T R Pieber
J K Mader
G Koehler
J Priedl
S Deller
C Dragatin
G Treiber
F Feichtner
K Glettler
M Bodenlenz
Published In
Biomed Tech (Berl)
Diabetes Obes Metab
Diabet Med
Drugs Aging
Skin Res Technol
Affiliations
Soon will be listed here.
Recent Articles
1.
Counter-regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trial
Pieber T, Deller S, Korsatko S, Jensen L, Christiansen E, Madsen J, et al.
Diabetes Obes Metab . 2015 Apr; 17(8):742-50. PMID: 25855340
Aims: To investigate the effect of glucagon-like peptide 1 receptor agonist liraglutide on the counter-regulatory hormone response to hypoglycaemia in type 1 diabetes. Methods: We conducted a randomized, double-blind, placebo-controlled,...
2.
Ultra-long pharmacokinetic properties of insulin degludec are comparable in elderly subjects and younger adults with type 1 diabetes mellitus
Korsatko S, Deller S, Mader J, Glettler K, Koehler G, Treiber G, et al.
Drugs Aging . 2013 Nov; 31(1):47-53. PMID: 24263619
Background: Management of diabetes in elderly subjects is complex and careful management of glucose levels is of particular importance in this population because of an increased risk of diabetes-related complications...
3.
Continuous Blood Glucose Monitoring (Cgm) System Based on Intravenous Microdialysis and Glucose Sensing
Greiner H, Schaller-Ammann R, Huber A, OConnell M, Krejci J, Porro G, et al.
Biomed Tech (Berl) . 2013 Sep; 58 Suppl 1. PMID: 24042873
No abstract available.
4.
Optimising the glucose sampling performance of an intravascular microdialysisbased continuous glucose monitoring device for use in hospital settings
Mader J, Lucarelli F, Scuffi C, Aberer F, Korsatko S, Valgimigli F, et al.
Biomed Tech (Berl) . 2013 Sep; 58 Suppl 1. PMID: 24042783
No abstract available.
5.
Certified dOFM sampling devices provide access to target tissue in pharmaceutical trials
Bodenlenz M, Dragatin C, Hoefferer C, Birngruber T, Priedl J, Feichtner F, et al.
Biomed Tech (Berl) . 2013 Sep; 58 Suppl 1. PMID: 24042762
No abstract available.
6.
PaQ®, a simple 3-day basal/bolus insulin delivery device, in people with type 2 diabetes
Mader J, Lilly L, Aberer F, Pachatz J, Korsatko S, Damsbo P, et al.
Biomed Tech (Berl) . 2013 Sep; 58 Suppl 1. PMID: 24042634
No abstract available.
7.
Pharmacodynamics of the long-acting insulin analogues detemir and glargine following single-doses and under steady-state conditions in patients with type 1 diabetes
Koehler G, Treiber G, Wutte A, Korsatko S, Mader J, Semlitsch B, et al.
Diabetes Obes Metab . 2013 Jul; 16(1):57-62. PMID: 23841569
Aim: The pharmacodynamic characteristics of the basal insulin analogues insulin detemir (IDet) and insulin glargine (IGlar) have been examined extensively via euglycaemic clamp studies. However, differences in clamp methodology and...
8.
Clinical applicability of dOFM devices for dermal sampling
Bodenlenz M, Aigner B, Dragatin C, Liebenberger L, Zahiragic S, Hofferer C, et al.
Skin Res Technol . 2013 Apr; 19(4):474-83. PMID: 23581539
Background: Sampling the dermal interstitial fluid (ISF) allows the pharmacokinetics and pharmacodynamics of dermatological drugs to be studied directly at their site of action. Dermal open-flow microperfusion (dOFM) is a...
9.
A direct comparison of the pharmacodynamic properties of insulin detemir and neutral protamine lispro insulin in patients with type 1 diabetes
Korsatko S, Glettler K, Olsen K, Wutte A, Bock G, Koehler G, et al.
Diabetes Obes Metab . 2012 Sep; 15(3):241-5. PMID: 23013357
Aims: To compare the pharmacodynamic properties of insulin detemir (detemir) and neutral protamine lispro (NPL) insulin using a euglycaemic glucose clamp. Methods: In a double-blind, crossover study, 30 patients with...
10.
Assessment of different techniques for subcutaneous glucose monitoring in Type 1 diabetic patients during 'real-life' glucose excursions
Mader J, Weinhandl H, Kohler G, Plank J, Bock G, Korsatko S, et al.
Diabet Med . 2010 Jun; 27(3):332-8. PMID: 20536497
Aims: To compare the accuracy of two marketed subcutaneous glucose monitoring devices (Guardian RT, GRT; GlucoDay S, GDS) and standard microdialysis (CMA60; MD) in Type 1 diabetic patients. Methods: Seven...